RNWL
INTERNATIONAL REGISTRATION RENEWED
06/10/2023
Voltar para busca
Dado oficial do USPTO
FKB
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
FKB
ST13
US500000079313063Classe
5, 10, 35, 40, 42, 44
Pedido
79313063
Registro
6810852
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
05/11/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 35, 40, 42, 44
Data de depósito
10/05/2021
Data de registro
09/08/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/08/2022
Última transação
05/11/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
JP
Examinador
KAPLAN, VALERIE
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd.
Representantes
Kaushal Odedra ODEDRA LAW OFFICE, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35Classe 40Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases; pharmaceutical preparations for use in connection with humans for the treatment of parasitic diseases; pharmaceutical preparations for use in connection with humans for the prevention of parasitic diseases; pharmaceutical preparations for use in connection with humans for the treatment of neoplasms; pharmaceutical preparations for use in connection with humans for the prevention of neoplasms; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the blood; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the blood; pharmaceutical preparations for use in connection with humans for the treatment of diseases of blood-forming organs; pharmaceutical preparations for use in connection with humans for the prevention of diseases of blood-forming organs; pharmaceutical preparations for use in connection with humans for the treatment of diseases of certain disorders involving the immune mechanism; pharmaceutical preparations for use in connection with humans for the prevention of diseases of certain disorders involving the immune mechanism; pharmaceutical preparations for use in connection with humans for the treatment of endocrine diseases; pharmaceutical preparations for use in connection with humans for the prevention of endocrine diseases; pharmaceutical preparations for use in connection with humans for the treatment of nutritional diseases; pharmaceutical preparations for use in connection with humans for the prevention of nutritional diseases; pharmaceutical preparations for use in connection with humans for the treatment of metabolic diseases; pharmaceutical preparations for use in connection with humans for the prevention of metabolic diseases; pharmaceutical preparations for use in connection with humans for the treatment of mental disorders; pharmaceutical preparations for use in connection with humans for the prevention of mental disorders; pharmaceutical preparations for use in connection with humans for the treatment of behavioural disorders; pharmaceutical preparations for use in connection with humans for the prevention of behavioural disorders; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the nervous system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the nervous system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the eye; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the eye; pharmaceutical preparations for use in connection with humans for the treatment of diseases of eye adnexa; pharmaceutical preparations for use in connection with humans for the prevention of diseases of eye adnexa; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the ear; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the ear; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the mastoid process; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the mastoid process; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the circulatory system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the circulatory system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the respiratory system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the respiratory system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the digestive system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the digestive system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the skin; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the skin; pharmaceutical preparations for use in connection with humans for the treatment of diseases of subcutaneous tissue; pharmaceutical preparations for use in connection with humans for the prevention of diseases of subcutaneous tissue; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the musculoskeletal system pharmaceutical preparations for use in connection with humans for the prevention of diseases of the musculoskeletal system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the connective tissue; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the connective tissue; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the genitourinary system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the genitourinary system; pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases and diabetes occurred in pregnancy; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases and diabetes occurred in pregnancy; pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases occurred in childbirth; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases occurred in childbirth; pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases occurred in the puerperium; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases occurred in the puerperium; pharmaceutical preparations for use in connection with humans for the treatment of nutritional deficiency conditions originating in the perinatal period; pharmaceutical preparations for use in connection with humans for the prevention of nutritional deficiency conditions originating in the perinatal period; pharmaceutical preparations for use in connection with humans for the treatment of congenital malformations; pharmaceutical preparations for use in connection with humans for the prevention of congenital malformations; pharmaceutical preparations for use in connection with humans for the treatment of deformations; pharmaceutical preparations for use in connection with humans for the prevention of deformations; pharmaceutical preparations for use in connection with humans for the treatment of chromosomal abnormalities; pharmaceutical preparations for use in connection with humans for the prevention of chromosomal abnormalities; prescribed pharmaceutical preparations for the treatment of infectious diseases; prescribed pharmaceutical preparations for the prevention of infectious diseases; prescribed pharmaceutical preparations for the treatment of parasitic diseases; prescribed pharmaceutical preparations for the prevention of parasitic diseases; prescribed pharmaceutical preparations for the treatment of neoplasms; prescribed pharmaceutical preparations for the prevention of neoplasms; prescribed pharmaceutical preparations for the treatment of diseases of the blood; prescribed pharmaceutical preparations for the prevention of diseases of the blood prescribed pharmaceutical preparations for the treatment of diseases of blood-forming organs; prescribed pharmaceutical preparations for the prevention of diseases of blood-forming organs; prescribed pharmaceutical preparations for the treatment of diseases of certain disorders involving the immune mechanism; prescribed pharmaceutical preparations for the prevention of diseases of certain disorders involving the immune mechanism; prescribed pharmaceutical preparations for the treatment of endocrine diseases; prescribed pharmaceutical preparations for the prevention of endocrine diseases; prescribed pharmaceutical preparations for the treatment of nutritional diseases; prescribed pharmaceutical preparations for the prevention of nutritional diseases; prescribed pharmaceutical preparations for the treatment of metabolic diseases; prescribed pharmaceutical preparations for the prevention of metabolic diseases; prescribed pharmaceutical preparations for the treatment of mental disorders; prescribed pharmaceutical preparations for the prevention of mental disorders; prescribed pharmaceutical preparations for the treatment of behavioural disorders; prescribed pharmaceutical preparations for the prevention of behavioural disorders; prescribed pharmaceutical preparations for the treatment of diseases of the nervous system; prescribed pharmaceutical preparations for the prevention of diseases of the nervous system; prescribed pharmaceutical preparations for the treatment of diseases of the eye; prescribed pharmaceutical preparations for the prevention of diseases of the eye; prescribed pharmaceutical preparations for the treatment of diseases of eye adnexa; prescribed pharmaceutical preparations for the prevention of diseases of eye adnexa; prescribed pharmaceutical preparations for the treatment of diseases of the ear; prescribed pharmaceutical preparations for the prevention of diseases of the ear; prescribed pharmaceutical preparations for the treatment of diseases of the mastoid process; prescribed pharmaceutical preparations for the prevention of diseases of the mastoid process; prescribed pharmaceutical preparations for the treatment of diseases of the circulatory system; prescribed pharmaceutical preparations for the prevention of diseases of the circulatory system; prescribed pharmaceutical preparations for the treatment of diseases of the respiratory system; prescribed pharmaceutical preparations for the prevention of diseases of the respiratory system; prescribed pharmaceutical preparations for the treatment of diseases of the digestive system; prescribed pharmaceutical preparations for the prevention of diseases of the digestive system; prescribed pharmaceutical preparations for the treatment of diseases of the skin; prescribed pharmaceutical preparations for the prevention of diseases of the skin; prescribed pharmaceutical preparations for the treatment of diseases of subcutaneous tissue; prescribed pharmaceutical preparations for the prevention of diseases of subcutaneous tissue; prescribed pharmaceutical preparations for the treatment of diseases of the musculoskeletal system; prescribed pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; prescribed pharmaceutical preparations for the treatment of diseases of the connective tissue; prescribed pharmaceutical preparations for the prevention of diseases of the connective tissue; prescribed pharmaceutical preparations for the treatment of diseases of the genitourinary system; prescribed pharmaceutical preparations for the prevention of diseases of the genitourinary system; prescribed pharmaceutical preparations for the treatment of infectious diseases and diabetes occurred in pregnancy; prescribed pharmaceutical preparations for the prevention of infectious diseases and diabetes occurred in pregnancy; prescribed pharmaceutical preparations for the treatment of infectious diseases occurred in childbirth; prescribed pharmaceutical preparations for the prevention of infectious diseases occurred in childbirth; prescribed pharmaceutical preparations for the treatment of infectious diseases occurred in the puerperium; prescribed pharmaceutical preparations for the prevention of infectious diseases occurred in the puerperium; prescribed pharmaceutical preparations for the treatment of nutritional deficiency conditions originating in the perinatal period; prescribed pharmaceutical preparations for the prevention of nutritional deficiency conditions originating in the perinatal period; prescribed pharmaceutical preparations for the treatment of congenital malformations; prescribed pharmaceutical preparations for the prevention of congenital malformations; prescribed pharmaceutical preparations for the treatment of deformations; prescribed pharmaceutical preparations for the prevention of deformations; prescribed pharmaceutical preparations for the treatment of chromosomal abnormalities; prescribed pharmaceutical preparations for the prevention of chromosomal abnormalities; biological pharmaceutical preparations for the treatment of infectious diseases; biological pharmaceutical preparations for the prevention of infectious diseases; biological pharmaceutical preparations for the treatment of parasitic diseases; biological pharmaceutical preparations for the prevention of parasitic diseases; biological pharmaceutical preparations for the treatment of neoplasms; biological pharmaceutical preparations for the prevention of neoplasms; biological pharmaceutical preparations for the treatment of diseases of the blood; biological pharmaceutical preparations for the prevention of diseases of the blood; biological pharmaceutical preparations for the treatment of diseases of blood-forming organs; biological pharmaceutical preparations for the prevention of diseases of blood-forming organs; biological pharmaceutical preparations for the treatment of diseases of certain disorders involving the immune mechanism; biological pharmaceutical preparations for the prevention of diseases of certain disorders involving the immune mechanism; biological pharmaceutical preparations for the treatment of endocrine diseases; biological pharmaceutical preparations for the prevention of endocrine diseases; biological pharmaceutical preparations for the treatment of nutritional diseases; biological pharmaceutical preparations for the prevention of nutritional diseases; biological pharmaceutical preparations for the treatment of metabolic diseases; biological pharmaceutical preparations for the prevention of metabolic diseases; biological pharmaceutical preparations for the treatment of mental disorders; biological pharmaceutical preparations for the prevention of mental disorders; biological pharmaceutical preparations for the treatment of behavioural disorders; biological pharmaceutical preparations for the prevention of behavioural disorders; biological pharmaceutical preparations for the treatment of diseases of the nervous system; biological pharmaceutical preparations for the prevention of diseases of the nervous system; biological pharmaceutical preparations for the treatment of diseases of the eye; biological pharmaceutical preparations for the prevention of diseases of the eye; biological pharmaceutical preparations for the treatment of diseases of eye adnexa; biological pharmaceutical preparations for the prevention of diseases of eye adnexa; biological pharmaceutical preparations for the treatment of diseases of the ear; biological pharmaceutical preparations for the prevention of diseases of the ear; biological pharmaceutical preparations for the treatment of diseases of the mastoid process; biological pharmaceutical preparations for the prevention of diseases of the mastoid process; biological pharmaceutical preparations for the treatment of diseases of the circulatory system; biological pharmaceutical preparations for the prevention of diseases of the circulatory system; biological pharmaceutical preparations for the treatment of diseases of the respiratory system; biological pharmaceutical preparations for the prevention of diseases of the respiratory system; biological pharmaceutical preparations for the treatment of diseases of the digestive system; biological pharmaceutical preparations for the prevention of diseases of the digestive system; biological pharmaceutical preparations for the treatment of diseases of the skin; biological pharmaceutical preparations for the prevention of diseases of the skin; biological pharmaceutical preparations for the treatment of diseases of subcutaneous tissue; biological pharmaceutical preparations for the prevention of diseases of subcutaneous tissue; biological pharmaceutical preparations for the treatment of diseases of the musculoskeletal system; biological pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; biological pharmaceutical preparations for the treatment of diseases of the connective tissue; biological pharmaceutical preparations for the prevention of diseases of the connective tissue; biological pharmaceutical preparations for the treatment of diseases of the genitourinary system; biological pharmaceutical preparations for the prevention of diseases of the genitourinary system; biological pharmaceutical preparations for the treatment of infectious diseases and diabetes occurred in pregnancy; biological pharmaceutical preparations for the prevention of infectious diseases and diabetes occurred in pregnancy; biological pharmaceutical preparations for the treatment of infectious diseases occurred in childbirth; biological pharmaceutical preparations for the prevention of infectious diseases occurred in childbirth; biological pharmaceutical preparations for the treatment of infectious diseases occurred in the puerperium; biological pharmaceutical preparations for the prevention of infectious diseases occurred in the puerperium; biological pharmaceutical preparations for the treatment of nutritional deficiency conditions originating in the perinatal period; biological pharmaceutical preparations for the prevention of nutritional deficiency conditions originating in the perinatal period; biological pharmaceutical preparations for the treatment of congenital malformations; biological pharmaceutical preparations for the prevention of congenital malformations; biological pharmaceutical preparations for the treatment of deformations; biological pharmaceutical preparations for the prevention of deformations; biological pharmaceutical preparations for the treatment of chromosomal abnormalities; biological pharmaceutical preparations for the prevention of chromosomal abnormalities; bandages for dressings
Classe 10
Apparatus for drug administrationdrug delivery systemscomprised of injectorautoinjectorboth sold empty; therapeutic inhalerssold empty; high frequency electromagnetic therapy apparatus; oxygen inhalers for therapeutic purposes sold empty; ultraviolet radiator units for therapeutic purposes; defibrillators; pneumothorax apparatusmedical apparatus for diagnosing or treating respiratory conditions; heart pacemakers; mercury arc lamp units for therapeutic purposes; infrared radiator units for therapeutic purposes; puncture apparatus for therapeutic purposesmedical devices for closing wounds; lavage apparatus for therapeutic purposesapparatus for washing out body cavities; carbon arc lamp units for therapeutic purposes; injection syringessyringe barrels; injection needles; infusion apparatus for therapeutic purposesinfusion pumps for delivering measured amounts of solutions into the bloodstream over rime; ultrasonic therapy machines and apparatus; short wave therapy machines and apparatus; therapeutic bath apparatus and instrumentsappliances for washing body cavities; massage apparatus for medical purposes; low frequency electric therapy apparatus; static electric therapy apparatus; dialyzersblood component separation apparatus for medical purposes; acupuncture needles; sprayers for medical purposesdrug delivery sprayers sold empty; suture apparatus for medical purposessuture needles and suture materials; radioisotope therapy apparatus and instruments; incubators for babies; blood transfusion apparatus; containers and trays specially designed for transporting and holding pharmaceuticals; injection device for pharmaceuticals; injection instruments without needles; injection instruments with needles
Classe 35
Providing information concerning commercial sales in the field of pharmaceuticals
Classe 40
Custom manufacture of pharmaceuticals
Classe 42
Pharmaceutical research; pharmaceutical development
Classe 44
Pharmaceutical information services provided via the Internetproviding information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; medical information services provided via the Internet; providing medical information
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/01/2023
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
18/11/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
18/11/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/11/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/08/2022
GPNX
NOTIFICATION PROCESSED BY IB
30/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/05/2022
PUBO
PUBLISHED FOR OPPOSITION
24/05/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/05/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/04/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/04/2022
RFNT
REFUSAL PROCESSED BY IB
21/03/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/02/2022
RFRR
REFUSAL PROCESSED BY MPU
23/02/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/01/2022
CNRT
NON-FINAL ACTION WRITTEN
28/01/2022
DOCK
ASSIGNED TO EXAMINER
14/01/2022
MAFR
APPLICATION FILING RECEIPT MAILED
29/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/06/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
21/06/2021
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
11/06/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FKB ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.